HOKUTO Concludes Comprehensive Business Alliance with the Japanese Society for Cancer of the Colon and Rectum on Medical Information Dissemination (April 1, 2026)
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
HOKUTO Co., Ltd. announced a comprehensive business alliance with the Japanese Society for Cancer of the Colon and Rectum effective April 1, 2026, aimed at disseminating medical information through its clinical support app used by a third of doctors in Japan.
AI Analysis
Frequently Asked Questions
- Q: What agreement did HOKUTO make on April 1, 2026?
- A: HOKUTO concluded a comprehensive business alliance with the Japanese Society for Cancer of the Colon and Rectum on medical information dissemination.
- Q: Who is the clinical support app 'HOKUTO' designed for and how widely is it used?
- A: The clinical support app 'HOKUTO' is developed for doctors and is used by one in three doctors nationwide.
- Q: What is the purpose of the website named 'HOKUTO resident'?
- A: It is a clinical training hospital review site designed for medical students to support their information gathering.
- Q: How does HOKUTO assist doctors and medical students in their daily activities?
- A: HOKUTO supports the process of information gathering and utilization for both doctors and medical students.
- Q: What is the purpose of developing 'HOKUTO Marketing Solutions'?
- A: It leverages the clinical support app's characteristics to support pharmaceutical companies in their pharmaceutical promotion.